Navigation Links
Insulin Patch Pumps
Date:11/14/2011

NEW YORK, Nov. 14, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Insulin Patch Pumps

http://www.reportlinker.com/p0683744/Insulin-Patch-Pumps.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=NoCategory

The collapse of the inhaled insulin market in 2008 has resulted in programs focused on alternative insulin delivery technologies. It now appears that the patch pump – a device that represents the convergence of a transdermal reservoir system with an energy source and control technology – will be the next generation in the evolution in patient-friendly insulin administration. With four FDA-approved insulin patch pump products and twice as many serious development-stage devices, the next 36 months will be critical to market sector participants wishing to ascend to a leadership position in the market segment. With no room for post-market missteps, product reliability, ease-of-use and patient acceptance will be essential for market success.

Highlights

• Analyzes and evaluates insulin patch pump products and development-stage candidates and assesses risks and market potential

• Analyzes insulin patch pump product strategies, technologies and patch development issues

• Provides assessments of insulin patch pump products

• Provides market data and forecasts to 2015

• Profiles market sector participants, their product development activities and business strategies

Summary of Contents

Executive Summary

Diabetes Market Dynamics

Shifting Insulin Delivery Markets

Demand Drivers

Demographic Shifts

Managed Care Initiatives

Growth in Home Healthcare

Technology Market Drivers

Competitive Landscape

Patch Pump Device Strategies

Device/System Architecture

Drug Delivery Mechanism

Drug Reservoirs

Sized Patch Pumps

Handheld Remote Electronics

Accuracy and Dosing Variability

Alerts and Patient Notification

Special Features

FDA-Approved Insulin Patch Pumps – Analysis and Market Data

Finesse

OmniPod

Solo

V-Go

Development-Stage Insulin Patch Pumps – Assessments & Forecasts

Cellnovo

CeQur

Freehand

Jewel Pump

Medipacs

PassPort

Sensile Medical

Spring Hybrid Pump

SteadyMed

Market Factors

Regulations

U.S.

International

Trials & Approval

IP and Product Positioning

Sector Participant Company Profiles

To order this report:

: Market Research Report

Check our  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Halozyme Therapeutics Announces Positive Results From Enzyme-Augmented Insulin Pump Trial
2. Biodel Reports Top-Line Results From Pump Study of Experimental Insulins
3. Insulin Lispro - Comprehensive Patent Search
4. Insulin- Western Europe
5. Insulin- Global
6. Insulin- Eastern Europe
7. Halozymes Ultrafast Insulin Demonstrates Reduced Variability of Insulin Absorption for Type 1 Diabetes Patients Using Insulin Pumps
8. Analysis Compares Cost-Effectiveness of Premixed Insulin Analogs to Long-Acting Insulin Analogs in the Long-Term Treatment of Type 2 Diabetes in the U.S.
9. FDA Approves Updates to Lillys Humalog® (insulin lispro injection [rDNA origin]) Label
10. Asante Solutions Receives FDA Clearance for Pearl™ Insulin Pump
11. Independent Investigator Initiates Phase 1 Study of Biodels Ultra-Rapid-Acting Insulin Formulations in Patients Using Insulin Pumps
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and Company ... results for the third quarter of 2017 on Tuesday, ... call on that day with the investment community and ... The conference call will begin at 9 a.m. ... access a live webcast of the conference call through ...
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans Bioscience ... the use of wearable and home sensors for real-time ... Early Signal Foundation, a nonprofit organization focused on disruptive ... provide an affordable analytical system to record and integrate ... ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The American ... to become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer ... Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. ...
(Date:10/13/2017)... (PRWEB) , ... October 13, ... ... School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, ... professionals on guideline updates for the primary prevention of cardiovascular diseases during ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers ... companies have a waiver for care if the client has a cognitive impairment diagnosis. ... pays for care, is often waived, so the benefits from their insurance start immediately,” ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... DevOps and Agile Software Development, has been awarded a contract by the Center ... Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in ...
Breaking Medicine News(10 mins):